Benitec Biopharma’s (BNTC) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $28.00 price target on the biotechnology company’s stock. Several other equities analysts have also recently commented on BNTC. Baird R W upgraded Benitec Biopharma […]
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $28.00 price target on the biotechnology company’s stock. Several other equities analysts have also recently commented on BNTC. Baird R W upgraded Benitec Biopharma […]
